House Passes Bipartisan Amendment to Increase Funding in FY19 Budget; Restores Funding to FY09 Level
Thursday, June 28, 2018 — Today, Lung Cancer Alliance hailed the passage of a bipartisan amendment in the U.S. House of Representatives that secured an additional $6 million to the Department of Defense (DOD) Lung Cancer Research Program in the FY19 budget. This move, pushed by Congressmen Rick Nolan (D-MN) and Frank LoBiondo (R-NJ), restored research funding levels from $14 million to the original $20 million funding level approved in 2009 by Congress for the Congressionally Directed Medical Research Program (CDMRP) Lung Cancer Research Program.
For the last eight years, LCA has consistently lead advocacy efforts to increase federal research funding to the original funding level through the annual appropriations process by working with members of Congress including Reps. Nolan and LoBiondo through the Congressional Lung Cancer Caucus. This is the largest lung cancer research program – public or private – outside of the National Cancer Institute.
The Lung Cancer Research Program at CDMRP has played a critical role in supporting high-impact, innovative lung cancer research within the military and general public in several areas including risk assessment, prevention, early detection, diagnosis, treatment, survivorship and outcomes.
Full details about the CDMRP can be viewed here.
As a 12 year lung cancer survivor, thank you LCA! Congressmen Nolan & LoBiondo for reaching across the aisle and supporting lung cancer research I know this unrelenting disease that is close to your heart for
all those fighting for a breath of hope.
Best,
Mary JNe McKeon
Founding Member
A Breath of Hope Lung Foundation.
I’m literally in tears!! This is awesome. Will forge us forward in much needed research!! Advocacy is SO important in keeping lung cancer in the forefront !! Thanks to the tireless advocates and organizations that help in galvanizing the survivors and help in opening doors in Congress and Senate chambers to hear our plea!!